Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profileg
Dana-Farber’s Breast Oncology Center

@DFCI_BreastOnc

Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425

ID:1491159909794291720

linkhttps://www.dana-farber.org/breast-oncology-program/ calendar_today08-02-2022 21:20:39

3,9K Tweets

4,4K Followers

334 Following

Follow People
Kimia Sorouri, MD, MPH(@KimiaSorouriMD) 's Twitter Profile Photo
Kimia Sorouri, MD, MPH
@KimiaSorouriMD

6 months ago

📗 Just out in ACS Journal Cancer: We offer granular data exploring the conception & pregnancy outcomes of young BC survivors to inform patient counseling.

Thank you to Dr. Tal Sella, Dr. Shoshana Rosenberg, & Dr. Ann Partridge MD, MPH!

🔗doi.org/10.1002/cncr.3…

OncoAlert

📗 Just out in @JournalCancer: We offer granular data exploring the conception & pregnancy outcomes of young BC survivors to inform patient counseling. Thank you to Dr. Tal Sella, Dr. @ShoshRosenberg, & Dr. @AnnPartridgeMD! 🔗doi.org/10.1002/cncr.3… @OncoAlert #OncoAlert #bcsm
account_circle
DetecTogether(@DetecTogether) 's Twitter Profile Photo
DetecTogether
@DetecTogether

6 months ago

Dr. Burstein, Medical Oncologist at Dana-Farber is an internationally renowned expert. Watch as he talks about the importance of activating your own - what is all about: bit.ly/408R4vX awareness

Dr. Burstein, Medical Oncologist at @DanaFarber is an internationally renowned #breastcancer expert. Watch as he talks about the importance of activating your own #healthcare - what #3stepsdetect is all about: bit.ly/408R4vX #earlycancerdetection #breastcancerawareness
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo
Paolo Tarantino
@PTarantinoMD

6 months ago

Join us at (Dec 6th, 7 pm) to review evolving treatment strategies in HR+ early and metastatic breast cancer! Erika Hamilton, MD Komal Jhaveri Hope Rugo GRASP Living Beyond Breast Cancer 👉 bit.ly/HR2023T

Join us at #SABCS23 (Dec 6th, 7 pm) to review evolving treatment strategies in HR+ early and metastatic breast cancer! @ErikaHamilton9 @jhaveri_komal @hoperugo @GRASPtweets @LivingBeyondBC 👉 bit.ly/HR2023T
account_circle
Megan E. Tesch(@MeganTesch) 's Twitter Profile Photo
Megan E. Tesch
@MeganTesch

6 months ago

Huge congrats to former co-resident presenting our resource stewardship efforts to improve restrictive blood 🩸 transfusion practices in oncology patients BC Cancer at the ASCO meeting today! 🎉 Cheering you on from clinic! 👏🏻 Celebrations tonight! 💃🏼

Huge congrats to former co-resident #MaeAlghawas presenting our resource stewardship efforts to improve restrictive blood 🩸 transfusion practices in oncology patients @BCCancer at the @ASCO #ASCOQLTY23 meeting today! 🎉 Cheering you on from clinic! 👏🏻 Celebrations tonight! 💃🏼
account_circle
Dana-Farber News(@DanaFarberNews) 's Twitter Profile Photo
Dana-Farber News
@DanaFarberNews

6 months ago

“Despite metastatic breast cancer being an incurable stage of breast cancer, it is very treatable. And people diagnosed with breast cancer are doing better than they ever have before,' says Dana-Farber's Erica Mayer, MD, MPH (@elmayermd) on Boston 25 News:
ms.spr.ly/60139F86N

account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

📄New publication in Molecular Cancer Therapeutics examining combination therapies to improve the efficacy of in .
Read the full text here⬇️
pubmed.ncbi.nlm.nih.gov/37676980/
Polyak Lab Jennifer Guerriero, PhD Jun Qi Lab Kornelia Polyak

📄New publication in @MCT_AACR examining combination therapies to improve the efficacy of #immunotherapy in #TripleNegativeBreastCancer. Read the full text here⬇️ pubmed.ncbi.nlm.nih.gov/37676980/ #TNBC #BreastCancer @LabPolyak @JennGuerriero @JunQiLab #AnaGarridoCastro @nellage
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

We will be closing out month with our free online educational program for patients, families, and loved ones. Register today for our Virtual Forum Series today!
🔽👇🔽 👇
dana-farber.org/cancer-care/tr…

We will be closing out #BreastCancerAwareness month with our free online educational program for patients, families, and loved ones. Register today for our #EMBRACE #MetastaticBreastCancer Virtual Forum Series today! 🔽👇🔽 👇 dana-farber.org/cancer-care/tr…
account_circle
The Jimmy Fund(@TheJimmyFund) 's Twitter Profile Photo
The Jimmy Fund
@TheJimmyFund

6 months ago

Family supports triple-negative research, while keeping daughter’s legacy alive. Learn more, here: blog.jimmyfund.org/2023/10/family…

account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

Join Dr. Sara Tolaney (Sara Tolaney) and other oncology experts on Thurs Nov 9th 5:00 PM – 6:00 PM ET for a post Congress 2023 live webinar series on the implications of the recent data sets for the management of various cancer types. Register here: bit.ly/45FfLkT

account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

We will be closing out month with our free online educational program for patients, families, and loved ones. Register today for our Virtual Forum Series today!
🔽👇🔽 👇
dana-farber.org/cancer-care/tr…

We will be closing out #BreastCancerAwareness month with our free online educational program for patients, families, and loved ones. Register today for our #EMBRACE #MetastaticBreastCancer Virtual Forum Series today! 🔽👇🔽 👇 dana-farber.org/cancer-care/tr…
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

Don't miss this VuMedi video of Dr. Julia Wong discussing the study which examined the effectiveness of short-course radiation vs. standard treatment for patients choosing reconstruction after .
vumedi.com/video/fabrec-s…

Don't miss this @VuMedi video of Dr. Julia Wong discussing the #FABREC study which examined the effectiveness of short-course radiation vs. standard treatment for #BreastCancer patients choosing reconstruction after #Mastectomy. vumedi.com/video/fabrec-s…
account_circle
Oncology Brothers(@OncBrothers) 's Twitter Profile Photo
Oncology Brothers
@OncBrothers

6 months ago

Paolo Tarantino Would lean towards Sacituzumab… (love this article/simple image by Paolo Tarantino Sara Tolaney Ilana Schlam). This agent is active in such a heavily pre-treated population. This patient is young! If ECOG 2, then would lean towards Paclitaxel. Yes, we need real world data on ADC…

@PTarantinoMD Would lean towards Sacituzumab… (love this article/simple image by @PTarantinoMD @stolaney1 @IlanaSchlam). This agent is active in such a heavily pre-treated population. This patient is young! If ECOG 2, then would lean towards Paclitaxel. Yes, we need real world data on ADC…
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

📷

There's still time to register for our Forum Series’ Kick-Off Events on Saturday, October 28! Join us for a day of learning with Dana-Farber's Breast Oncology experts.
Register 👉dana-farber.org/metastatic-bre…

📷 There's still time to register for our #EMBRACE Forum Series’ Kick-Off Events on Saturday, October 28! Join us for a day of learning with @DanaFarber's Breast Oncology experts. Register 👉dana-farber.org/metastatic-bre…
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

We are leading a randomized Phase 2 trial for stage 1 HER2+ of T-DM1 followed by SQ trastuzumab versus TH (paclitaxel + SQ trastuzumab) ( 2.0).
For more information call 877-338-7425 or visit:
dana-farber.org/clinical-trial…

We are leading a randomized Phase 2 trial for stage 1 HER2+ #breastcancer of T-DM1 followed by SQ trastuzumab versus TH (paclitaxel + SQ trastuzumab) (#ATEMPT 2.0). For more information call 877-338-7425 or visit: dana-farber.org/clinical-trial…
account_circle
Dr Sarah Sammons(@drsarahsam) 's Twitter Profile Photo
Dr Sarah Sammons
@drsarahsam

6 months ago

These pumpkins in #JimmyFund walkway make me happy! 🍁🍂🎃Dana-Farber Dana-Farber’s Breast Oncology Center

These pumpkins in @StrikeoutCancer walkway make me happy! 🍁🍂🎃@DanaFarber @DFCI_BreastOnc
account_circle
Nancy Lin, MD(@nlinmd) 's Twitter Profile Photo
Nancy Lin, MD
@nlinmd

6 months ago

Great talk from Dr Matthias Preusser on the emerging role of ADCs in pts with brain metastases. Ongoing studies with T-DXd, Dato-DXD, and Patritumab-DXd!

Great talk from Dr Matthias Preusser on the emerging role of ADCs in pts with brain metastases. Ongoing studies with T-DXd, Dato-DXD, and Patritumab-DXd!
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc

6 months ago

Dr. Sarah Sammons (Dr Sarah Sammons) gave a brilliant presentation in our breast oncology seminar series ( ) on Novel Strategies in the Prevention and Treatment of

Dr. Sarah Sammons (@drsarahsam) gave a brilliant presentation in our breast oncology seminar series (#BOSS) on Novel Strategies in the Prevention and Treatment of #BreastCancerBrainMetastases #BCBM #BrainMets #MBC #BCSM #breastcancer
account_circle
Sara Tolaney(@stolaney1) 's Twitter Profile Photo
Sara Tolaney
@stolaney1

6 months ago

Fantastic presentation by Dr Sarah Sammons on breast cancer brain metastases at our DFCI breast oncology seminar series

Dana-Farber’s Breast Oncology Center

Fantastic presentation by @drsarahsam on breast cancer brain metastases at our DFCI breast oncology seminar series @DFCI_BreastOnc
account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo
Dana-Farber
@DanaFarber

6 months ago

Join Antonio Giordano, MD, PhD (Antonio Giordano, MD PhD) & Sarah Sammons, MD (@drsarahsam), as they discuss advances for patients with -positive on 10/28, part of the EMBRACE Forum Series.



ms.spr.ly/60189t6uC

Join Antonio Giordano, MD, PhD (@antgiorda) & Sarah Sammons, MD (@drsarahsam), as they discuss advances for patients with #ER-positive #MBC on 10/28, part of the EMBRACE #MetastaticBreastCancer Forum Series. #breastcancerresearch #breastcancerawareness ms.spr.ly/60189t6uC
account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo
Dana-Farber
@DanaFarber

6 months ago

Join Nancy Lin, MD (Nancy Lin, MD), and Adrienne Waks, MD, as they discuss advances for patients with -positive on 10/28, part of the EMBRACE Forum Series

Register today: ms.spr.ly/60139tpS5

Join Nancy Lin, MD (@nlinmd), and Adrienne Waks, MD, as they discuss advances for patients with #HER2-positive #MBC on 10/28, part of the EMBRACE #MetastaticBreastCancer Forum Series #breastcancerresearch #breastcancerawareness Register today: ms.spr.ly/60139tpS5
account_circle